Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024)
Whitehawk Therapeutics (WHWK) posted quarterly Current Leases of $268000.0 for Q4 2024, down 38.25% year-over-year from $434000.0 in Q1 2024, and down 16.77% quarter-over-quarter from $322000.0 in Q3 2024.
Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Current Leases for 6 consecutive years, with $268000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Current Leases fell 38.25% year-over-year to $268000.0; the TTM figure through Dec 2024 stood at $268000.0 (down 38.25% YoY), while the FY2024 annual figure was $268000.0, down 38.25% from the prior year.
- Current Leases retreated to $268000.0 in Q4 2024 per WHWK's latest filing, from $322000.0 in the prior quarter.
- Across five years, Current Leases topped out at $434000.0 in Q4 2023 and bottomed at $9955.0 in Q2 2021.
- Historically, Current Leases has averaged $251285.0 across 5 years, with a median of $295000.0 in 2024.
- Annual changes were most pronounced in 2021 — Current Leases slumped 91.04% — and 2022, when it soared 3154.65%.
- Whitehawk Therapeutics' Current Leases stood at $125000.0 in 2020, then climbed by 4.8% to $131000.0 in 2021, then soared by 200.76% to $394000.0 in 2022, then climbed by 10.15% to $434000.0 in 2023, then sank by 38.25% to $268000.0 in 2024.
- Business Quant data shows WHWK's Current Leases at $268000.0 in Q4 2024, $322000.0 in Q3 2024, and $374000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | 322,000.00 |
| Jun 30, 2024 | 374,000.00 |
| Mar 31, 2024 | 425,000.00 |
| Dec 31, 2023 | 434,000.00 |
| Sep 30, 2023 | 423,000.00 |
| Jun 30, 2023 | 413,000.00 |
| Mar 31, 2023 | 404,000.00 |
| Dec 31, 2022 | 394,000.00 |
| Sep 30, 2022 | 374,000.00 |
| Jun 30, 2022 | 324,000.00 |
| Mar 31, 2022 | 163,000.00 |
| Dec 31, 2021 | 131,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 9,955.00 |
| Mar 31, 2021 | 39,171.00 |
| Dec 31, 2020 | 125,000.00 |
| Sep 30, 2020 | 94,787.00 |
| Jun 30, 2020 | 111,053.00 |
| Mar 31, 2020 | 106,734.00 |